Sirio Pharma Co., Ltd. (SHE:300791)
China · Delayed Price · Currency is CNY 21.67
-0.28 (-1.28%)
At close: Feb 13, 2026
Sirio Pharma Revenue
Sirio Pharma had revenue of 1.25B CNY in the quarter ending September 30, 2025, with 18.11% growth. This brings the company's revenue in the last twelve months to 4.45B, up 7.90% year-over-year. In the year 2024, Sirio Pharma had annual revenue of 4.21B with 17.56% growth.
Revenue (ttm)
4.45B
Revenue Growth
+7.90%
P/S Ratio
1.49
Revenue / Employee
1.60M
Employees
2,776
Market Cap
6.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.21B | 629.04M | 17.56% |
| Dec 31, 2023 | 3.58B | 1.07B | 42.87% |
| Jan 1, 2023 | 2.51B | 138.31M | 5.84% |
| Dec 31, 2021 | 2.37B | 302.13M | 14.62% |
| Dec 31, 2020 | 2.07B | 487.26M | 30.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tangrenshen Group | 25.86B |
| Shanghai Bright Meat Group | 22.46B |
| Juewei Food | 5.50B |
| Ligao Foods | 4.26B |
| V V Food & Beverage Co.,Ltd | 3.36B |
| Beingmate | 2.72B |
| Yantai Shuangta Food | 2.27B |
| Guilin Seamild Foods | 2.16B |